; and (v) research scientists with experience conducting translational research or utilizing surveillance systems for scientific research purposes. (c) Objective of the Office In carrying out subsection (b), the Director of the Office shall facilitate and work to ensure the accomplishment of the following activities: (1) Expansion and enhancement of epidemiological research and basic, translational, and clinical biological and biomedical research. (2) Expansion and improvement of tick surveillance, linking tick surveillance to surveillance of Lyme disease, and reporting of Lyme disease and other tick- and vector-borne diseases, including coinfections with agents of more than one tick or vector-borne diseases. (3) Development of effective diagnostic tests to accurately and timely diagnose Lyme disease and other tick- and vector-borne diseases, including direct detention tests. (4) Development of treatments to cure or improve the lives of those who are infected with Lyme disease or other tick-and vector-borne diseases or who suffer from a tick-induced disorder (such as tick PIM programs). (5) Address the quality of patient care, treatment affordability, and public awareness of Lyme disease and other tick or vector-borne diseases. (6) Design and conduct clinical trials of sufficient size and duration to support clinical recommendations. (7) Systematic documentation of the experiences of health care professionals in diagnosing and treating tick- and vector-borne disease, including diagnostic and treatment outcomes. (8) Development and maintenance of one or more registries of patients and their experiences relating to exposure to, diagnosis for, and treatment of tick- and vector-borne disease, including outcomes, such that the confidentiality and safety of patient data is protected. (9) Access to data and enable emerging technologies to improve patient care, sharing data with researchers and care providers. (10) Coordination with other Federal departments to address tick- and other vector-borne diseases including the